VBIV logo

VBI Vaccines (VBIV) Enterprise Value

VBIV Enterprise Value

N/A

Mon, 01 Jan 0001 00:00:00 GMT

VBIV Enterprise Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV Enterprise Value Performance

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
6 m6 months---
1 y1 year---
5 y5 years---

VBIV Enterprise Value High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month$41 M$38 M
1 y1-year$61 M$38 M
3 y3-year$400 M$27 M
5 y5-year$1.38 B$27 M
alltimeall time$1.38 B-$6 M

VBI Vaccines Enterprise Value History

DateValue
2023
$43.68 M(-51.6%)
2022
$90.32 M(-82.4%)
2021
$514.40 M(-14.8%)
2020
$603.42 M(+176.7%)
2019
$218.09 M(+97.3%)
2018
$110.51 M(-49.6%)
2017
$219.07 M(+111.2%)
DateValue
2016
$103.73 M(+20.8%)
2015
$85.88 M(+306.2%)
2014
$21.14 M(+315.8%)
2013
$5.09 M(-83.6%)
2012
$30.94 M(-80.0%)
2011
$155.04 M(-3.6%)
2010
$160.82 M

FAQ

  • What is the all time high enterprise value for VBI Vaccines?

What is the all time high enterprise value for VBI Vaccines?

VBI Vaccines all-time high enterprise value is $1.38 B